BioAge Labs (BIOA) Change in Account Payables (2023 - 2026)

BioAge Labs has disclosed Change in Account Payables across 4 years of filings, most recently posting $326000.0 for Q1 2026.

• Change in Account Payables for Q1 2026 came in at $326000.0, down 84.07% year-over-year; the trailing twelve-month figure through Mar 2026 was -$933000.0 (down 155.14% YoY), and the FY2025 annual result was $788000.0, up 13033.33% from the prior year.
• Change in Account Payables came in at $326000.0 for Q1 2026 at BioAge Labs, up from -$2.3 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $3.6 million in Q3 2025 to a low of -$2.6 million in Q2 2025.
• The 4-year median for Change in Account Payables is $343500.0 (2024), against an average of $243200.0.
• Peak annual rise in Change in Account Payables reached 467.04% in 2025, while the deepest fall reached 1730.95% in 2025.
• BioAge Labs' Change in Account Payables stood at $1.3 million in 2023, then plunged by 109.6% to -$126000.0 in 2024, then tumbled by 1730.95% to -$2.3 million in 2025, then surged by 114.13% to $326000.0 in 2026.
• The last three Change in Account Payables figures came in at $326000.0 (Q1 2026), -$2.3 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.